A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers

Clinical trial NCT04980391 · TERMINATED

Trial details

NCT number: NCT04980391
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2021-08-03
Primary completion: 2023-05-30
Enrollment: 384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.